Mary Chapman,  features writer—

Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.

Articles by Mary Chapman

Supporters Poised for September, 10th World Alzheimer’s Month

Each September, people from around the globe come together to heighten awareness of Alzheimer’s disease and push back against stigmas around dementia. This year marks a decade of advocacy, as supporters observe the 10th World Alzheimer’s Month. Throughout the month, patients, caregivers, and advocates will share messages and stories…

June Is Alzheimer’s and Brain Awareness Month

From participating in a fundraiser on the longest day of the year, to sporting purple gear and sharing stories, supporters are marking Alzheimer’s & Brain Awareness Month, as they do each June. The purpose is to raise awareness among the general public, as well as among policymakers, public authorities,…

Association Endorses ENACT Act to Improve Clinical Trial Diversity

The Alzheimer’s Association and its advocacy affiliate, the Alzheimer’s Impact Movement (AIM), are backing recently introduced bipartisan legislation to support equity in Alzheimer’s disease clinical trials. The Equity in Neuroscience and Alzheimer’s Clinical Trials (ENACT) Act of 2021 (H.R. 3085/S. 1548) would amend the Public Health…

Brown University to Focus on Early Diagnosis, Treatment

Brown University is establishing the Center for Alzheimer’s Disease Research to build a world-class research program that is focused on the early detection and treatment of Alzheimer’s disease and related disorders. The center is made possible by separate gifts of $25 million and $5 million from donors who wish…

UsAgainstAlzheimer’s Calls for $289M Hike in Federal Funds for Research

To meet a U.S. goal to effectively treat and prevent Alzheimer’s disease by 2025, patient, caregiver, and advocacy communities are recommending a $289 million hike in federal research dollars for fiscal year 2022. UsAgainstAlzheimer’s is supporting that recommendation — and calling for greater urgency in meeting national Alzheimer’s…

HFC to Host CareCon, Virtual Event for Caregivers

A virtual celebrity-studded HFC event aimed at caregivers for Alzheimer’s disease and dementia patients is on tap for Friday, National Caregivers Day. Called HFC CareCon and presented by Kensington Senior Living in both English and Spanish, the free two-hour event will be hosted by HFC co-founder and actor…

Support for Research, Patient Care in US 2021 Budget Wins Praise

The Alzheimer’s Association and its advocacy affiliate, the Alzheimer’s Impact Movement (AIM), are lauding recent actions by lawmakers that will fund and advance multiple Alzheimer’s disease policies. The advancements are part of the $1.4 trillion government funding bill for the 2021 fiscal year that was passed by Congress on Dec. 21 and…

Awareness Month Activities Shine Spotlight on Alzheimer’s, Dementia

Efforts are underway this month to focus attention on Alzheimer’s, a disease that, along with other forms of dementia, affects some 44 million people globally and is swiftly growing in prevalence. During November in the U.S., Alzheimer’s Awareness Month observances include fundraisers, disseminating tips for healthy aging, downloadable Alzheimer’s information,…